Saturday, October 31, 2026

Farmers Edge Sees Exercise Of Over-Allotment Option, Bringing IPO Proceeds To $143.8 Million

Farmers Edge (TSX: FDGE) has seen further capital inflows in connection with its initial public offering. The firm this morning announced that it has now received an additional $18.8 million in funds as a result of the full exercise of its over-allotment option that was issued in connection with the financing.

A total of 1.1 million common shares were issued under the over-allotment option, bringing in $18,750,150 in additional funds, with common shares of the issuer sold at a price of $17.00 each. The additional sale brings total gross proceeds from the initial public offering, or IPO, to $143.8 million.

Farmers Edge last traded at $16.47 on the TSX.

Silver47 Exploration Inc. — sponsored Sponsored · Silver47 Exploration Inc.

Information for this briefing was found via Farmers Edge and Sedar. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Copper Mine Costs 1/6 to Restart | SSR Mining X Roxmore

Why Cambria Hit Pause on Its Massive Copper-Gold Spinout

Can Gold Rescue Washington From Its Debt Trap? | Andy Schectman – Miles Franklin

Recommended

Mercado Minerals Lengthens El Triunfo Vein by 190 Metres, Readies 1,500-Metre Zamora Drill Program

Blue Jay Gold Signs Ocean Partners Deal to Ship Steller Stockpiles Through 2027

Related News

Healthcare Reimbursement Firm MSP Recovery To Be Taken Public In A US$32.6 Billion SPAC Merger

Health insurance reimbursement platform MSP Recovery (Nasdaq: MSPR) closed its business combination with special purpose...

Thursday, May 26, 2022, 02:21:00 PM

SPAC Welsbach Technology Metals Acquisition Prices US$75 Million IPO

Special purpose acquisition company Welsbach Technology Metals Acquisition Corp. (Nasdaq: WTMAU) started trading publicly on...

Wednesday, December 29, 2021, 02:18:00 PM

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market...

Friday, March 25, 2022, 02:22:00 PM

Medical Cannabis Firm Akanda Prices US$16 Million IPO

International medical cannabis firm Akanda Corp. (Nasdaq: AKAN) goes public today on the Nasdaq Capital...

Tuesday, March 15, 2022, 02:26:00 PM

Semrush: The IPO Deep Dive

Semrush (NYSE: SEMR) is an online platform that offers a suite of tools to companies,...

Thursday, March 25, 2021, 12:31:00 PM